Ignite Creation Date:
2024-05-05 @ 6:33 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00506519
Status:
TERMINATED
Last Update Posted:
2021-08-31
First Post:
2007-07-23
Brief Title:
Recombinant Human Antithrombin ATryn in the Treatment of Patients With DIC Associated With Severe Sepsis
Sponsor:
LEO Pharma
Organization:
LEO Pharma
Organization Data
Organization:
LEO Pharma
Class:
INDUSTRY
Study ID:
LEO 90010-I21
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
LEO Pharma
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None